Other
OCI - Available-for-Sale Securities, Net of Tax
Year-over-year, this metric declined by 847.1%, from $1.7M to -$12.7M. Over 3 years (FY 2021 to FY 2025), OCI - Available-for-Sale Securities, Net of Tax shows an upward trend with a 0.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ1 2018
Last reportedQ1 2026May 5, 2026
How to read this metric
Positive values indicate an increase in the market value of the investment portfolio, while negative values indicate a decrease.
Detailed definition
This represents the unrealized gains or losses on debt securities classified as available-for-sale, net of the associate...
Peer comparison
Common in companies with large cash reserves invested in debt instruments.
Metric ID:
msft_oci_available_for_sale_securities_net_of_taxHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$300K | -$300K | -$2.1M | -$7.6M | -$2.9M | -$1.8M | $4M | $700K | $800K | $7M | -$3.2M | -$900K | $9.1M | -$5.1M | $1.7M | $2.7M | -$900K | $0 | -$12.7M |
| QoQ Change | — | +0.0% | -600.0% | -261.9% | +61.8% | +37.9% | +322.2% | -82.5% | +14.3% | +775.0% | -145.7% | +71.9% | >999% | -156.0% | +133.3% | +58.8% | -133.3% | +100.0% | — |
| YoY Change | — | — | — | — | -866.7% | -500.0% | +152.6% | +124.1% | +144.4% | — | -180.0% | -228.6% | >999% | -172.9% | +153.1% | +400.0% | -109.9% | +100.0% | -847.1% |
Range-$12.7M – $9.1M
CAGR+129.9%
Avg YoY Growth-56.7%
Median YoY Growth-4.9%
OCI - Available-for-Sale Securities, Net of Tax at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's oci - available-for-sale securities, net of tax?
- Neurocrine Biosciences (NBIX) reported oci - available-for-sale securities, net of tax of -$12.7M in Q1 2026.
- How has Neurocrine Biosciences's oci - available-for-sale securities, net of tax changed year-over-year?
- Neurocrine Biosciences's oci - available-for-sale securities, net of tax decreased by 847.1% year-over-year, from $1.7M to -$12.7M.
- What is the long-term trend for Neurocrine Biosciences's oci - available-for-sale securities, net of tax?
- Over 3 years (2021 to 2025), Neurocrine Biosciences's oci - available-for-sale securities, net of tax has grown at a 0.0% compound annual growth rate (CAGR), from -$3.5M to $3.5M.
- What does oci - available-for-sale securities, net of tax mean?
- The change in value of investment securities that has not yet been realized through a sale.